Hoxton Ventures has announced the final close of Hoxton Ventures II L.P., an early stage European venture capital fund building on the firm’s record of finding and investing in “unicorns,” which includes seed investments in Babylon Health, Darktrace and Deliveroo.  Hoxton’s strategy of finding European companies that can scale globally into large, category-defining leaders in newly forming industries has led it to becoming one of Europe’s top-performing early stage venture capital firms. The firm’s first fund has the highest ratio of unicorns to investments, according to Dealroom.